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Bone undergoes continuous remodelling throughout adult
life, and the equilibrium between bone formation by
osteoblasts and bone resorption by osteoclasts defines
the final bone mass. Here we show that Snail1 regulates
this balance by controlling osteoblast differentiation.
Snail1 is necessary for the early steps of osteoblast devel-
opment, and it must be downregulated for their final
differentiation. At the molecular level, Snail1 controls
bone mass by repressing the transcription of both the
osteoblast differentiation factor Runx2 and the vitamin D
receptor (VDR) genes in osteoblasts. Sustained activation
of Snail1 in transgenic mice provokes deficient osteoblast
differentiation, which, together with the loss of vitamin D
signalling in the bone, also impairs osteoclastogenesis.
Indeed, the mineralisation of the bone matrix is severely
affected, leading to hypocalcemia-independent osteomala-
cia. Our data show that the impact of Snail1 activity on the
osteoblast population regulates the course of bone cells
differentiation and ensures normal bone remodelling.
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Introduction
The integrity of the bone depends on the balance between
bone resorption by osteoclasts and bone formation by osteo-
blasts (Karsenty and Wagner, 2002). Indeed, imbalances
between these two processes lead to a number of diseases
(Rodan and Martin, 2000). Although increased bone mass
may be due to osteoclast dysfunction (osteopetrosis) or to
high osteoblast activity (osteosclerosis), a reduction in bone
mass is usually caused by increased osteoclast number or
activity, sometimes accompanied by suppression of osteo-
blast activity (osteoporosis). Defective mineralisation of the
bone matrix associated with defects in the vitamin D signal-
ing leads to osteomalacia. In addition, osteoclast differentia-
tion directly depends on osteoblast activity (Boyle et al,
2003), as they secrete osteoclastogenic factors, such as the
receptor for activation of nuclear factor kappa B ligand
(RANKL), macrophage colony stimulating factor (M-CSF)
and osteoprotegerin (OPG) (Lagasse and Weissman, 1997;
Lacey et al, 1998). Thus, a tight control of osteoblast differ-
entiation is necessary to ensure the appropriate balance
between bone formation and bone resorption in the adult.
Runx2 is the main transcriptional regulator of osteoblast
differentiation. It is required for both the commitment of
mesenchymal cells to the osteoblast lineage and the late
stages of osteoblast differentiation and bone mineralisation
(Ducy et al, 1997; Komori et al, 1997; Otto et al, 1997;
Nakashima and de Crombrugghe, 2003; Xiao et al, 2005).
Although the mechanisms that control Runx2 activity at the
post-translational level are already known (Bialek et al, 2004;
Jones et al, 2006), regulators of its transcription in osteoblasts
remain to be identified.
Snail genes are transcriptional repressors best known by
their ability to trigger the epithelial to mesenchymal transi-
tion (EMT), endowing epithelial cells with motility and
invasive properties (Barrallo-Gimeno and Nieto, 2005;
Peinado et al, 2007). In addition to the regulation of cell
movements and adhesion, Snail factors have a broad spec-
trum of biological functions, including the regulation of cell
proliferation and survival (Vega et al, 2004). Interestingly,
Snail also functions in non-epithelial cells, such as chondro-
cytes, where it is unable to induce EMT but still controls
proliferation. Indeed, its deregulated expression in the
developing bone leads to achondroplasia in transgenic mice,
the most common form of dwarfism in humans (de Frutos et al,
2007). Achondroplasias are associated with activating muta-
tions in FGFR3, which signal in a ligand-independent manner
to impair chondrocyte proliferation and differentiation
(Ornitz and Marie, 2002). Snail1 is the transcriptional effector
of FGFR3 signaling during bone development and disease,
and its activity can be inversely correlated with the length of
the long bones (de Frutos et al, 2007). As in other tissues,
Snail1 expression is very tightly regulated in the bone, and
thus, we wondered whether its aberrant activation in the
adult had any impact on bone homeostasis. Indeed, our data
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highlight the fundamental role of Snail1 in controlling bone
mass by acting as a repressor of both Runx2 and VDR
transcription during osteoblast differentiation.
Results
Sustained Snail1 activation in osteoblasts leads
to osteomalacia in transgenic mice
We showed recently that Snail1 activity regulates longitudinal
bone growth by controlling chondrocyte proliferation and
differentiation (de Frutos et al, 2007). However, Snail1 trans-
cripts are also found in the perichondral area (Supplementary
Figure 1A), suggesting that it might also be expressed by
osteoblasts. Indeed, we have found intense Snail1 expression
in osteoblasts from mouse calvaria (Figure 1A). As Snail
transcription factors are pleiotropic proteins involved in
different cellular processes depending on the cell context
(Barrallo-Gimeno and Nieto, 2005), we examined whether
Snail1 might also fulfil additional roles in bone formation. To
address this issue, we took advantage of our conditional
transgenic mouse model in which Snail1 could be activated
in the developing bones (Snail1-ER; de Frutos et al, 2007; see
also Materials and methods and Supplementary Figure 1).
To avoid interference with the effects of Snail1 on long-
itudinal bone growth (de Frutos et al, 2007), we have only
analysed adult animals here. In this model, constitutively
expressed exogenous Snail1 protein only becomes active on
nuclear translocation induced by tamoxifen administration.
Accordingly, the transgenic Snail1-ER protein was expressed
in the osteoblasts of both the trabecular and the cortical
bones, and it was efficiently translocated to the nucleus on
tamoxifen administration (Supplementary Figure 1B). On
Snail1 activation, cartilage-bone staining highlighted defi-
ciencies in the ossification of the long bones in these mice
as assessed by Von Kossa staining (Figure 1C and D and
Supplementary Figure 2). The images shown in Figure 1C and
D are representative of the phenotype observed in around
two thirds of the Snail1-ER tamoxifen-treated mice (20 mice
analysed per condition in four independent experiments).
Cortical thickness was not affected as assessed in Van
Gieson stained transverse sections of the tibias (not
shown). In the vertebrae, around 15% of the matrix was
not calcified (Figure 1B, E and F). The histomorphometric
analysis also revealed that when total bone volume was
considered as both mineralised bone and osteoid, as estab-
lished previously (Parfitt et al, 1987), the total bone volume
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Figure 1 Snail1 activation induces a bone mineralisation defect in adult transgenic mice. (A) RT–PCR showing Snail expression in osteoblasts
(OB) but not in osteoclasts (OC). (B) Percentage of osteoid volume versus total bone volume (OV/TV) determined histomorphometrically in
vertebrae (n¼ 5). (C, D) Von Kossa staining of sections of long bones from 16-week-old Snail1-ER transgenic mice shows defective
mineralisation as assessed by the deficit in calcium salt deposits (black staining) after 8 weeks of tamoxifen administration. Insets show
higher magnification of the cortical bone regions. (E, F) Von Kossa staining of vertebral sections. Scale bars, 1 mm, ANOVA analysis (***)
Po0.001. (G–J) (G, H) Calcein labelling of WT tibiae showing that virtually all trabecular and cortical bone was labelled after 8 days of
injections, whereas 2 months after the end of the treatment, labelling was not detectable in the trabeculae and in cortical area located below the
growth plate. (I, J) Similar results were obtained in vertebrae in which only scarce calcein labelling was detectable in cortical bone and in the
trabecular area 2 months after the end of the treatment.
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did not significantly change (Supplementary Figure 3).
Similarly, the trabeculae were similar in number and thick-
ness (Supplementary Figure 3). The deficient mineralisation
was more severe in the tibia than in the vertebrae and indeed,
in around 20% of the treated animals the majority of the
cortex and some trabeculae were composed of only osteoid
tissue 2 months after Snail1 activation commenced. As the
mice had well mineralised bones before tamoxifen adminis-
tration, it appears that bone remodelling is very rapid. To
confirm this, we analysed the rate of remodelling in wild-type
mice by injecting calcein for 8 consecutive days into wild-
type mice, and assessing the labelling that remained at
different time points. This labelling had decreased 1 month
after the injection (not shown), and it was greatly diminished
after 2 months, particularly in the tibia and the vertebrae
(Figure 1G–J). Hence, the strong phenotype that we observed
in our transgenic mice was compatible with Snail1 inducing a
defect in bone formation, and on the other hand, it is very
reminiscent of osteomalacia or defective bone mineralisation
(Karsenty and Wagner, 2002).
Snail1 represses VDR transcription in osteoblasts
and impairs osteoclastogenesis
Osteomalacia has been associated with a deficit in vitamin D
or its signalling through the VDR receptor (Li et al, 1997;
Yoshizawa et al, 1997). However, the primary role of vitamin
D signalling in bone mineralisation is to stimulate intestinal
absorption of calcium. Indeed, dietary restoration of mineral
ion homeostasis prevents osteomalacia in VDR mutant mice
(Li et al, 1998; Amling et al, 1999). As Snail1 directly
represses the transcription of the Vdr gene in human colon
cancer cells (Palmer et al, 2004; Pena et al, 2005), the
osteomalacia phenotype of Snail1-ER mice could be due to
a deficient VDR expression in the intestine and low calcium
absorption. However, as the Snail1-ER transgenic protein was
not expressed in the intestine, this does not appear to be the
case (Supplementary Figure 4A–E). Consequently, VDR pro-
tein expression and distribution as well as the morphology of
the intestine were unaffected by tamoxifen administration
(Supplementary Figure 4F–M). Consistent with this finding,
calcium and phosphate serum levels were normal in the
Snail1-ER tamoxifen-treated mice (Figure 2A and B).
Moreover, serum levels of creatinine and urea (not shown)
were also unaffected, indicating that tamoxifen administra-
tion to Snail1-ER mice did not affect the kidneys, as might be
expected from the very low levels of transgenic protein in the
kidney (not shown). Although the serum levels of alkaline
phosphatase were elevated in the tamoxifen-treated mice
(Figure 2C), this increase was very modest compared with
that observed in VDR mutants (Yoshizawa et al, 1997; Panda
et al, 2004). Interestingly, we also found normal serum levels
of the vitamin D3 precursor 25(OH)D3 (Figure 2D) and
normal expression levels of its hydroxylase Cyp27b1 in
both kidney and bone (Figure 2E and F).
Although an ion-rich diet can rescue osteomalacia in VDR
mutant mice, the number of osteoclasts remains low because
VDR signalling is also required in osteoblasts for osteoclast
differentiation (Panda et al, 2004). As such, VDR is
also expressed in osteoblasts, where it directly activates
the promoter of the osteoclast differentiation factor RANKL and
downregulates the expression of OPG, a decoy RANKL
receptor that inhibits osteoclastogenesis (Simonet et al, 1997;
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Figure 2 Aberrant Snail1 activation impairs osteoclastogenesis.
Calcium (A), phosphate (B), alkaline phosphatase (ALP, C) and
25(OH)D3 (D) concentrations in serum samples from 16-week-old
mice after 8 weeks of corn oil or tamoxifen administration. The
results are expressed as the means±s.d. from five samples. (E, F)
The 25(OH)D3 hydroxylase Cyp271b is unaltered in both the kidney
and the bone of Snail1-ER transgenic mice regardless of whether
tamoxifen is administered. (G) Snail1 activation inhibits vitamin D
receptor mRNA expression and protein accumulation. (H) Snail1
activation is also accompanied by a decrease in the expression of
the Rankl osteoclastogenic factor and an increase in that of the
osteoclastogenesis inhibitor Osteoprotegerin. The results are ex-
pressed as the mean±s.d. from three independent experiments
carried out on limbs obtained from 16-week-old Snail1-ER mice
after 8 weeks of treatment with tamoxifen. (I, J) Osteoclasts are
revealed by tartrate-resistant acid phosphatase (TRAP) staining.
Sections are counterstained with alcian blue. (K) Quantification of
the osteoclast population by histomorphometric analysis of bones
from 16-week-old wild-type and Snail1-ER mice (n¼ 10). (L–N)
Osteoclast differentiation in culture is not affected by Snail1 activa-
tion. Oc.N., osteoclast number; B.Pm., bone perimeter. Scale bar,
100mm. ANOVA analysis, **Po0.01 and ***Po0.001.
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Kitazawa et al, 2003; Kondo et al, 2004). We examined
whether Snail1 could repress Vdr transcription in the bone
as it does in colon cancer cells, and we found that Snail1
activation on tamoxifen administration did indeed repress of
both Vdr transcription and protein accumulation (Figure 2G).
This inhibition of Vdr expression impairs the activation of
Rankl expression and increases Osteoprotegerin levels
(Figure 2H), which could explain the reduction observed in
the osteoclast population (Figure 2I–K). We also examined
the chondrocytes, as the deletion of VDR in these cells also
provokes a reduction in osteoclastogenesis due to decreased
RANKL expression (Masuyama et al, 2006). Tamoxifen did
not affect Rankl expression (not shown) in chondrocytes
differentiated from dissociated 14.5 dpc hindlimb cells
obtained from transgenic embryos as described previously
(de Frutos et al, 2007). Finally, although endogenous Snail1 is
not expressed in the osteoclast population (Figure 1A), we
examined whether the transgenic protein might be expressed
in these cells, possibly contributing to the impaired osteoclast
differentiation observed in the Snail1-ER mice treated with
tamoxifen. Transgenic osteoclasts do not express Snail1-ER
(not shown) and their differentiation in cultures was similar
in wild-type and transgenic animals, although tamoxifen
seemed to slightly decrease the efficiency of the process in
both cases (Figure 2L–N). Together, these data indicate that
on the one hand, the impaired osteoclastogenesis was due to
the defects in VDR signalling in osteoblasts that diminished
the availability of RANKL, and on the other hand, that there
is no cell-autonomous defect in the osteoclast population or
defects in VDR signalling in chondrocytes. Thus, with respect
to VDR signalling, the Snail1-ER mice represent an osteo-
blast-specific model for VDR deficiency.
Transient Snail1 expression is required for osteoblast
differentiation
Although bone-specific repression of VDR transcription by
Snail1 can explain the defects in osteoclastogenesis in the
transgenic mice, it cannot account for the defective miner-
alisation given that ion homeostasis is maintained. Thus, we
decided to assess the rate of bone formation by examining
calcein incorporation after its injection in vivo. The strong
impairment in calcein apposition observed was compatible
with the defective mineralisation observed in these bones
(Figure 3A and B), and suggesting that the osteoblasts failed
to fully differentiate. Indeed, the bones from Snail1-ER
tamoxifen-treated mice expressed higher levels of Collagen I
transcripts and lower levels of Osteocalcin expression in
Snail1-ER bones (Figure 3C and E), markers of early and
late osteoblast differentiation, respectively (Nakashima and
de Crombrugghe, 2003), while the number of osteoblasts
remained similar (Figure 3F and G).
To examine the role of Snail1 in osteoblast differentiation,
we developed an in vitro system from embryonic bones in
which the stages of proliferation, differentiation and miner-
alisation could be followed. This culture system accurately
reproduced the differentiation pattern described previously
(Maes et al, 2007), in terms of osteoblasts differentiated from
wild-type embryos or from transgenic Snail1-ER embryos in
the absence of tamoxifen (Figure 4A–C). We found that
Snail1 was transiently expressed in a profile that closely
resembled that of Collagen I, probably reflecting the indirect
induction of Collagen I expression by Snail1 as occurs in
kidney epithelial cells (Boutet et al, 2006). The expression of
phospho-histone 3, p21 or p27 was not altered when cells
from transgenic embryonic bones differentiated to osteoblasts
in the presence of tamoxifen, indicating that unlike in chon-
drocytes (de Frutos et al, 2007), Snail1 does not affect
osteoblast proliferation (Supplementary Figure 5).
Transgenic Snail1 activation by nuclear translocation on
tamoxifen administration (Figure 4D) was correlated with cell
commitment to the osteoblast lineage. Mesenchymal cells
were converted into immature osteoblasts as they expressed
Osteopontin and upregulated Collagen I expression (Komori,
2008). However, sustained Snail1 activation prevented them
from continuing their differentiation (Figure 4E).
Significantly, the normal maturation process was recovered
on Snail1 inactivation due to its cytoplasmic relocalisation
after tamoxifen removal. Collagen I and Osteopontin expres-
sion were downregulated, and the transcription of the Bone
Sialoprotein, Osteocalcin, Dentin matrix protein 1 (Dmp1)
and the transmembrane endopeptidase Phex began to in-
crease (Figure 4F and G; see also Supplementary Figure 6).
The expression of ATF4, an osteoblast marker not regulated at
the transcriptional level, was unaltered regardless of the state
of Snail1 activity (Supplementary Figure 6). In summary,
our data indicate that although Snail1 downregulation was
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Figure 3 Aberrant Snail1 activation impairs calcein apposition.
(A, B) Mineral apposition was visualised after calcein injection
(n¼ 5 per group). (C–E) Snail1 activation increases the transcrip-
tion of the early differentiation osteoblast markers Type I Collagen
and alkaline phosphatase (Alp; only a slight increase) and decreases
that of the differentiated population marker Osteocalcin. Real-time
PCR was carried out on limbs obtained from 16-week-old Snail1-ER
mice after 8 weeks of treatment with tamoxifen. The results
are expressed as mean±s.d. from three independent experiments.
(F, G) The number of osteoblasts per bone perimeter is unaltered on
Snail1 activation. Histomorphometric analysis of bones from 16-
week-old wild-type and Snail1-ER mice (n¼ 10). Ob.S., osteoblast
surface; Ob.N., osteoblast number; B.S., bone surface; B.Pm., bone
perimeter. ANOVA analysis, *Po0.1 and **Po0.01.
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necessary for osteoblast differentiation, it might be required
for the initial steps in the differentiation process. To assess
whether this was indeed the case, Snail1 siRNA was trans-
fected into wild-type primary cultures derived from 14.5 dpc
embryonic hindlimbs at the time of endogenous Snail1
induction. Snail1 was almost totally silenced (Figure 4H)
and differentiation was completely abolished (Figure 4I).
Thus, Snail1 is necessary at early stages of osteoblast differ-
entiation and must be downregulated for differentiation and
mineralisation to proceed. Given the role of Snail1 in osteo-
blast differentiation, it is likely that it also contributes to
intramembranous ossification.
Snail1 directly controls Vdr and Runx2 transcription
during osteoblast differentiation
Having determined that Snail1 regulates osteoblast differen-
tiation in culture, and given that it is a transcription factor, we
set out to define its targets. Having shown that VDR expre-
ssion was inhibited in bones when Snail1 was activated, we
analysed Vdr expression in our osteoblast differentiation
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system. As expected, Vdr expression inversely correlated
with that of Snail1 (Figure 5A) and, furthermore, its tran-
scription remained repressed in the presence of activated
Snail1 (Figure 5B). As Snail1 directly inhibits Vdr trans-
cription in colon cancer cells as assessed in promoter activity
assays (Palmer et al, 2004), we examined whether it could
also bind to its promoter in osteoblasts. Three consensus
E-boxes for Snail binding exist in a 0.5-kb fragment upstream
of the Vdr coding region (Cano et al, 2000; Figure 5C).
Chromatin immunoprecipitation (ChIp) analyses of osteo-
blasts from Snail1-ER transgenic mice confirmed that
Snail1-ER can bind to boxes II and III and as expected, only
in the presence of tamoxifen (Figure 5C). In these ChIp
experiments, the ER-antibody was used to detect only the
exogenous Snail1-ER fusion protein and not the endogenous
Snail1 that would bind to the promoter in the presence or
absence of tamoxifen administration. These data confirm
that Snail1 also binds directly to the Vdr promoter in
osteoblasts.
Besides VDR, Runx2 was a clear candidate target to
examine, as it is considered the main regulator of osteoblast
differentiation, and it is first required for the commitment of
mesenchymal cells to the osteogenic and osteoblast lineage
(Ducy et al, 1997; Komori et al, 1997; Otto et al, 1997;
Nakashima and de Crombrugghe, 2003). Later on, Runx2 is
also required for the conversion of these cells to mature
osteocytes and for the expression of mineralisation proteins
(e.g., osteocalcin; Xiao et al, 2005). We analysed Runx2
expression in our osteoblast differentiation system and as
for Vdr, Runx2 transcription was inversely correlated with
that of Snail1 (Figure 5D). This relationship suggested that
Snail1 might repress Runx2, compatible with the repression
of Runx2 observed in transgenic osteoblasts cultured in
the presence of tamoxifen (Figure 5E). Furthermore, Snail1
transfection in differentiating osteoblasts induced sustained
repression of Runx2 transcription (Figure 5F), although
Runx2 was expressed strongly after transfection of a Snail1
siRNA (Figure 5F). These data indicate that Snail1 may act as
a Runx2 repressor, and this led us to assess whether Snail1
could directly repress Runx2 promoter activity.
Nine consensus E-boxes for Snail binding exist in an 8-kb
fragment upstream of the Runx2 coding region (Figure 6A).
However, only the two most proximal boxes were conserved
between human and mouse. Using a reporter construct that
included these two boxes, we found that Snail1 decreased the
activity of the Runx2 promoter in osteoblasts (Figure 6A;
construct 1). Although deletion or mutations of the distal
E-box of this pair (constructs 2 and 5) did not affect repressor
activity, deletion or mutations in the most proximal box
significantly relieved the repression of the Runx2 promoter
(Figure 6A; constructs 3 and 4). Moreover, simultaneous
mutations in the two boxes completely abrogated inhibition.
The sequences deleted in construct number 3 (Figure 6A) are
likely to contain binding sites for Runx2 activators, as its
activity in the absence of Snail1 is much lower than that of
the control fragment (construct 1). Together, these data
indicate that the binding of Snail1 to the most proximal box
is sufficient to inhibit Runx2 promoter activity and that the
second box cooperates in this repression.
A similar ChIp analysis of osteoblasts from Snail1-ER
transgenic mice confirmed that like the Vdr promoter,
Snail1-ER can also only bind to these two conserved boxes
in the Runx2 promoter in the presence of tamoxifen
(Figure 6B). Interestingly, Snail1 is unable to bind to four
additional consensus boxes or to the three perfect-match
E-boxes contained in 3 kb or between 7 and 8 Kb fragments
upstream of the Runx2 coding region, respectively (Figure 6B
and Supplementary Figure 7).
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Although our culture system reproduced the described
pattern of osteoblast differentiation, we decided to analyse
whether Snail1 also behaved as a Runx2 repressor in vivo. We
first examined the endogenous pattern of Snail1 expression in
the perichondral area of mouse embryos throughout fetal
development. We found that Snail1 expression was very
dynamic, and that it followed a similar profile to that found
in our cultures, with a peak of high expression at 16.5 dpc
(Figure 7C). Interestingly, Snail1 expression was inversely
correlated with that of Runx2 both in the perichondral area
and in the trabecular bone (Figure 7A–J). These data are
compatible with the repression of Runx2 by Snail1. As such,
we also found that Runx2 is repressed in Snail1-ER transgenic
bones on Snail1 activation in vivo (Figure 7K–N). In addition,
the direct downstream target of Runx2, Osterix (Nakashima
et al, 2002; Nishio et al, 2006), was also inhibited on Snail1
activation in these bones (not shown). These data validate
the specificity of the transfection and ChIp assays and con-
firm that Snail1 directly binds to the Runx2 promoter and
represses its transcription during osteoblast differentiation.
Discussion
We have shown that Snail1 directly represses both VDR and
Runx2 transcription during osteoblast differentiation. The
transitory expression of Snail1 in osteoblasts can control
the course of differentiation by facilitating an early and
a late phase of Runx2 activity. Sustained activation of
Snail1 in mice stabilises the normally transient repression
of transcriptional cascades downstream of Runx2 and Vdr in
osteoblasts, inducing defective mineralisation and impairing
osteoclastogenesis, respectively. When coupled with the
Snail1-mediated induction of Collagen I, these alterations
generate uncalcified matrix or osteoid and thus, osteomalacia
independent of hypocalcemia and hypophosphatemia.
Despite the in vivo data obtained in this study come from a
transgenic mouse model overexpressing Snail1, we believe
that it significantly helps understand the mechanisms that
control bone formation and resorption. It reveals an unex-
pected and important role of Snail1 in osteoblast differentia-
tion in culture, which is compatible with the data obtained in
transgenic mice (Figure 8). Although our model is not
osteoblast specific, we have ruled out the cell-autonomous
contribution of chondrocytes or osteoclasts in these processes
in our mice. On the one hand, Snail1-ER protein is not
expressed in osteoclasts, and on the other hand, we have
not seen any defect in chondrocytes that could explain the
observed phenotype. We show that Snail1 controls Vdr
expression in osteoblasts. It is known that impaired Vdr
signalling in the intestine leads to osteomalacia due to
defective calcium absorption in the intestine. However,
Snail1 cannot be associated with VDR signalling or calcium
uptake in the intestine in healthy conditions, as Snail1 is not
endogenously expressed in normal intestinal tissue. Similarly,
this transgenic line of Snail1-ER mice does not express Snail1
in the intestine either and maintained normal VDR expression
and serum ion levels. Thus, with respect to VDR signalling,
Snail1-ER mice provide an osteoblast-specific defective
model, where Snail1-mediated repression of Vdr transcription
in osteoblasts leads to defects in osteoclastogenesis due to the
consequent deregulation of Rankl and Osteoprotegerin.
Interestingly, Snail1 is aberrantly activated in colon cancer
cells, where it represses Vdr expression (Palmer et al, 2004),
as it normally occurs in osteoblasts (this work). Perhaps the
benefits of a higher calcium intake associated with a reduced
risk of colon cancer detection (Wu et al, 2002) can be related
to a compensation of deficient calcium uptake in patients
with impaired VDR signalling after aberrant activation of
Snail1 as part of the transformation process.
Importantly, our studies also help to clarify the temporal
regulation of Runx2 transcription during normal bone devel-
opment and homeostasis. Undifferentiated mesenchymal
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Figure 6 Snail1 is a direct repressor of Runx2 transcription.
(A) Diagram of the 8-kb region upstream of the translational
initiation site in the mouse Runx2 gene showing the putative sites
for Snail1 binding (E-boxes). Two of these boxes are conserved in
the human (black squares). Luciferase reporter constructs carrying
the wild-type Runx2 promoter or deletions/mutations in the two
conserved E-boxes were assayed in osteoblasts together with either
the mouse Snail1 expression vector or an empty vector as a control
(pcDNA3). Luciferase activity was measured 24 h after transfection,
and the activity was expressed relative to that of the wild-type
construct. The results are expressed as the mean values±s.e. of
duplicates from four independent experiments. Snail1 repressed the
activity of the wild-type Runx2 promoter, but it did not affect the
promoter constructs in which the most proximal conserved E-box
was deleted or mutated. (B) Chromatin immunoprecipitation (ChIP)
assays carried out in osteoblasts differentiated from Snail1-ER
transgenic mice confirm that Snail1 only binds to these two con-
served proximal E-boxes and only on tamoxifen administration. M,
fragment length markers; In (the input material), immunoprecipita-
tion positive control H3 (sample immunoprecipitated with anti-H3
antibody) and immunoprecipitation negative control GFP (sample
immunoprecipitated with anti-GFP antibody) were tested with
GAPDH primers. The input material was also tested for each primer
set corresponding to the fragments containing all the putative
binding sites (see Supplementary Figure 7).
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cells have low levels of Snail1, allowing the expression of
Runx2 transcripts. However, Runx2 activity is low at these
early stages due to its interaction with Twist proteins, which
prevent the Runx2 protein from binding to its target promo-
ters (Bialek et al, 2004). When Twist is downregulated, Runx2
becomes functional and by blocking adipocyte and chondro-
cyte differentiation, it activates osteoblast formation. It is
known that Runx2 must be later suppressed for immature
osteoblasts to continue differentiating (Komori, 2008), and
later on, it needs to be re-expressed as it is essential for
terminal differentiation into osteocytes and complete miner-
alisation (Stein et al, 2004; Xiao et al, 2005). Our data
showing the transient nature of Snail1 expression during
osteoblast differentiation and its ability to act as a direct
transcriptional repressor of Runx2, provide an explanation for
this complex dynamics of Runx2 expression throughout the
differentiation process. As such, at the time when Runx2 has
specified the osteoblast phenotype, Snail1 is activated and
transiently represses Runx2 so that differentiation to the
immature osteoblast can proceed. In addition to inhibiting
Runx2 expression, Snail1 actively favours the formation of
immature osteoblasts, as it is necessary for Collagen I and
Osteopontin expression (Figure 4H) and represses the expres-
sion of the mineralisation genes Phex and Dmp1. Subsequent
Snail1 downregulation releases Runx2 transcriptional repres-
sion and allows mineralisation to proceed, as this second
wave of Runx2 expression is necessary to activate Bone
Sialoprotein and Osteocalcin (Stein et al, 2004). On miner-
alisation, the levels of Runx2 protein are controlled by
Schnurri-3, which promotes its degradation in the protea-
some (Jones et al, 2006).
In conclusion, we have revealed Snail1 to be the first
transcriptional repressor of Runx2, which together with the
post-translational regulation co-ordinated by Twist and
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Schnurri-3 (Bialek et al, 2004; Jones et al, 2006), controls the
complex dynamics of Runx2 protein activity during osteo-
blast differentiation. Snail1 also favours the synthesis
of unmineralised matrix by indirectly activating Collagen I
expression and it controls osteoclastogenesis by directly
repressing Vdr transcription. Thus, Snail1 lies upstream of
three fundamental pathways in bone remodelling and the
control of adult bone mass (Figure 8). Our data indicate that
aberrant expression of Snail1 would lead to osteomalacia
even under normal ion homeostasis conditions as it occurs in
the presence of vitamin D and a wild-type Vdr gene. In
addition, this study provides further insight into the complex
regulation of bone formation and resorption.
Materials and methods
Mice
The Snail-ERT2 construct (de Frutos et al, 2007) was microinjected
into fertilised C57CBA hybrid eggs to generate transgenic mice
according to Hogan et al (1994). A line was selected that expressed
significant levels of the transgenic protein in the adult bone,
immunohistochemically detecting the transgenic protein with a
human estrogen-receptor antibody (Santa Cruz). All mice were
killed by cervical dislocation.
Induction with tamoxifen or 4-OH-Tamoxifen
Tamoxifen (Sigma) was dissolved in corn oil at a concentration of
30 mg/ml. Corn oil, alone or containing tamoxifen, was injected
intraperitoneally every 2 days. Tamoxifen was injected at a
concentration of 200 mg or 75 mg/g of body weight to 8-week-old
animals for 8 weeks or to pregnant females at 12.5 and 14.5 dpc,
respectively. A 1-mM stock solution of 4-OH-Tamoxifen (Sigma)
was prepared in ethanol and further diluted to the appropriate
concentrations before its use in cultures.
Embryo dissection and in situ hybridisation
Embryos were dissected at 12.5–18.5 dpc and fixed overnight in 4%
paraformaldehyde. Hindlimbs were decalcified in 22.5% formic
acid and 10% sodium citrate at 41C for 24 h and subsequently, they
were gelatin-embedded before obtaining 30–50 mm vibratome
sections. In situ hybridisation was performed as previously
described in Cano et al (2000), and the plasmids used to obtain
digoxigenin riboprobes corresponded to the following cDNA
sequences: Snail1 (1–1600 bp) and Runx2 (484–650 bp).
Skeleton staining
The hindlimbs were dissected and the skin was removed. The limbs
were fixed in 10% formalin, and the cartilage was stained with
Alcian Blue. After washing, the limbs were trypsinised and stained
with Alizarin Red S (for calcium salts), cleared by KOH treatment
and stored in glycerol.
Histology and histomorphometric analyses
Non-decalcified bones were embedded in methylmethacrylate
according to standard protocols (Parfitt et al, 1987) before
processing them for Von Kossa, tartrate resistant acid phosphatase
(TRAP) staining or histological analysis. Mice were injected with
100 ml of a calcein solution (5 mg/ml), both 6 and 2 days before they
were killed, and they were then processed for plastic embedding as
described above. In the bone-remodelling assay, injections were
given on 8 consecutive days, and mice were killed 1 week (to
confirm labelling efficiency), 1 or 2 months after the last injection.
Measurements were performed with the Osteo Measure Analysis
System (Osteometrics) using a 3CCD color video DXC-390 camera
(Sony) coupled to a microscope (DMLB; Leica). Statistical
differences between groups were assessed by the t-test.
Immunohistochemistry
Histological sections were prepared from hindlimbs fixed in 10%
formalin that were decalcified with 22.5% formic acid in 10%
sodium citrate at room temperature for 16 h, and embedded in
gelatin. Gelatin sections (100 mm) were stained using an anti-hER
antibody (Santa Cruz) diluted 1:200, and they were developed with
the ABC reagent (Pierce) according to the manufacturer’s instruc-
tions. Other histological sections were prepared from tissues fixed
in 10% formalin and embedded in paraffin. Paraffin sections (5 mm)
were stained with haematoxylin and eosin or subjected to
immunohistochemistry with antibodies against either the anti-
human estrogen receptor (a-hER, 1:200; Santa Cruz) or anti-VDR
(a-VDR, 1:200; Chemicon) antibodies. The appropriate Alexa 488
secondary antibodies were used diluted 1:5000 in 1% BSA in PBS.
Calvaria primary cultures
Osteoblasts were isolated from enzymatically dissociated calvaria
from 3-day-old mice, and they were plated in differentiation
medium: a-MEM (Invitrogen) containing 10% heat-inactivated
serum (Sigma–Aldrich), 50 mg/ml ascorbic acid and 10 mM sodium
b-glycerophosphate. After 24 h, the cells were harvested with 0.01%
trypsin in PBS, and they were then plated in 35 mm culture dishes at
2104 cells/dish and grown for 22 days in the differentiation
medium. Total cellular mRNA was extracted from primary
osteoblasts with RNA-Now (Eurobio, Les Ulis, France).
Primary osteoclast cultures
Osteoclast cell cultures were established with spleen cells from 6- to
8-week-old OF1 male mice or Snail1-ER mice, whereby 2500 or
4000 cells/mm2 were seeded and cultured for 8 days. Bone marrow
mononuclear cells from 8-week-old WT or Snail1-ER mice were
plated on 96-wells plate at the density ranging from 104 cells to
5104 per well, and the following day (D1) treated with 200 nM
tamoxifen (Sigma) or vehicle for 6 days. All cultures were carried
out in the presence of a-MEM (Invitrogen) containing 10% (v/v)
foetal calf serum (FCS, Biowest, Nuaille, France), M-CSF (20 ng/ml)
and RANKL (50 ng/ml) from R&D system. Osteoclast differentiation
was evaluated by TRAP staining using the leukocyte acid
phosphatase kit from Sigma.
Primary osteoblast cultures
Hindlimbs from 14.5 dpc transgenic or wild-type mouse embryos
were dissected in medium (a-MEM, 1% BSA, 0.1% L-Glutamine,
0.1% penicillin/streptomycin) and left overnight at 371C and 5%
CO2. The following day, the bones were trypsinised for 10–15 min at
371C and digested for 2 h in 3 mg/ml Collagenase P in DMEM with
10% FCS at 371C. The reaction was inactivated by adding primary
culture media (50% F-12, 50% DMEM, 10% FCS, 0.1%
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Figure 8 Diagram showing the central position of Snail1 in the
bone remodelling pathways. In wild-type mice, Snail1 is necessary
for the first steps of osteoblast differentiation in a dual manner.
It activates the expression of the early differentiation markers
Collagen I and Osteopontin while it inhibits Runx2 expression,
necessary for differentiation to proceed. The transient nature of
Snail1 expression allows a second wave of Runx2 transcription
needed for bone mineralisation. On the other hand, Snail also
directly represses Vdr transcription in osteoblasts providing another
link between osteoblastogenesis and osteoclastogenesis.
Consequently, sustained Snail1 activation in adult Snail1-ER mice
supports the formation of the osteoid but inhibits osteoblast and
osteoclast terminal differentiation, leading to a defective mineral
deposition.
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L-Glutamine, 0.1% penicillin/streptomycin), and the cells were
plated at a density of 1.5106 cells/P100 in primary culture media
(Woods and Beier, 2006). After 5 days in culture, the cells were
seeded at a density of 1105 per well and differentiated to
osteoblasts in differentiation media (50% F-12, 50% DMEM,
0.1% L-Glutamine, 0.1% penicillin/streptomycin, 10 mM b-glycero-
phosphate, 100 nM dexamethasone, 0.2 mM ascorbic acid (Reyes
et al, 2001) in the presence or absence of 200 nM 4-OH-Tamoxifen,
and the medium was changed every 2 days. Cells were transfected
after 2 days in differentiation medium using Lipofectamine
(Invitrogen) with Snail1 siRNA or the random negative control,
and/or an expression plasmid containing the Snail1-coding region
(CR), RNA was isolated every 2 days using the SIGMA Genelute
Mammalian Total RNA Kit according to the manufacturer’s
instructions. The siRNA duplex oligonucleotide used was described
previously (de Frutos et al, 2007). Immunofluorescence was carried
out using antibodies against either anti-collagen I or II (1:50,
Calbiochem), anti-hER (1:200, Santa Cruz) or anti-PH3 (1:100,
Upstate) antibodies and the appropriate Alexa 488 secondary
antibodies.
Western blotting
For immunoblotting, cells were lysed in 50 mM Tris (pH 7.5),
150 mM NaCl, 0.1% SDS, 0.5% Deoxycholate and 1% Triton X-100
supplemented with a standard protease inhibitor standard mix
(1 mM NaF, 1 mM b-glycerophosphate, 5 mM NaPPi, 5 mg/ml
Leupeptine, 1 mM Vanadate and 100mg/ml PMSF). Total protein
(50mg per lane) was separated on a denaturing 12% SDS–PAGE gel
and then transferred to PVDF membranes, which were then blocked
with 0.1% Tween-20 and 3% low-fat milk in PBS. The membranes
were then incubated in the same solution with anti-hER (1:200;
Santa Cruz) or anti-total ERK2 (1:500; Santa Cruz) antibodies, and
finally with the appropriate horseradish peroxidase-conjugated
secondary antibody. Quantification was performed with the L
Process v2.0 software from Bioimager Fujifilm.
Quantitative PCR
Quantitative RT–PCR was carried on an ABI PRISMs 7000 sequence
detection system using the Syber Greens method. RNA expression
was calculated using the comparative Ct method normalised to
GAPDH. In experiments on complete bones, data were expressed
relative to a calibrator (wild-type mice without tamoxifen) using the
2(DDCt)±s.d. formula. For cell culture experiments, data were
normalised using the C0±s.d. formula to compare the relative
expression between the different genes. Data are represented as the
mean±s.d. of triplicates from a representative experiment (n¼ 3).
ANOVA analysis, *Po0.1, **Po0.01, ***Po0.001.
RT–PCR
Total mRNA (1mg) was reverse-transcribed using a random primer
and Super Script III RT (Promega). PCR was performed with specific
primers for mouse Snail1, Runx2 and Gapdh. The products
amplified were separated in agarose gels and quantified with the
L Process v2.0 software from Bioimager Fujifilm.
Promoter analyses
Runx2 promoter activity was measured by cotransfecting primary
osteoblast cultures with 50 ng of pcDNA3-Snail1 or empty pcDNA3
vectors and 400 mg of pcL2-Runx2 promoter fragments-Luc.
A Renilla reniformis luciferase plasmid (phRL-CMV-Luc from
Promega) was also cotransfected as a control for efficiency. Firely
and renilla luciferase activity were measured 48 h after transfection
using the Dual Luciferase Reporter Assay System (Promega)
according to the manufacturer’s instructions. The results are
presented as the percentage of Luciferase activity relative to control
(Luciferase values in cells cotransfected with an empty vector).
ChIP assays
Cells were crosslinked with formaldehyde before DNA sonication.
Chromatin was immunoprecipitated with antibodies against rabbit
anti-hER (Santa Cruz), anti-H3 (Abcam), as a positive control, or
anti-GFP (Invitrogen), as a negative control. In all cases, chromatin
was sheared to an average length of 0.5–1 kb. Primers were
designed to amplify fragments of 100–200-bp from the mouse
Runx2 promoter containing one of the nine E-boxes or from the
mouse Vdr promoter containing one of the three E-boxes identified
by sequence analysis. The control samples (immunoprecipitated
with H3 or GFP antibodies) were amplified with Gapdh primers.
Supplementary data
Supplementary figures include the characterisation of transgenic
protein nuclear translocation on tamoxifen administration, the
analysis of bone mass and bone cells in control animals, the
analysis of VDR in the intestine of wild-type and transgenic mice,
the effects of the absence of Snail1 on osteoblast proliferation, the
analysis of Snail1 binding to distal E-boxes in the Runx2 promoter
and a Table with the sequences of all oligonucleotides used.
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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